Blog
Featured post
Truveta Data includes linked closed claims for over 200 million patients
By linking complete clinical data with comprehensive claims records, Truveta advances real-world evidence (RWE) generation that can replace, or complement, clinical trials and registries.
Latest trends in two-dose vaccination against measles among children in the US
The vaccination rate by age six fluctuated between 2018 and 2021; however, rates have decreased since 2021. The rate in 2021 was 81.9% compared to 80.4% in 2024. This means for...
Latest US first-time measles vaccination trends for children under 24 months
Measles vaccination rates for children under 24 months in 2024 remain lower than in 2020. In 2024, the average yearly measles vaccination rate for children by 13 months was...
Why women experience more GLP-1 side effects: New research from Olio Labs using Truveta Data
GLP-1 drugs like Ozempic and Zepbound are transforming obesity treatment, yet 40-85% of patients are plagued by adverse GI events—particularly women. New research from Olio Labs,...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through February 2025
The overall rate of respiratory virus-associated hospitalizations decreased in February, although influenza continues to be the leading cause of respiratory virus-associated...
Making Americans healthier – with data
At Truveta, our mission is Saving Lives with Data, and we are thinking about the HHS leadership mission of making American’s healthier, and how to help the talented scientists of...
New administrative data in Truveta Data and features in Truveta Studio help researchers accelerate scientifically rigorous research
Today, we're excited to celebrate our latest innovation in Truveta across both Truveta Data and Truveta Studio. Truveta Data has expanded to include new administrative data to...
Beyond trials: How real-world data is transforming autoimmune research
Why autoimmune research needs better real-world data Biologics like Humira, Enbrel, and Rinvoq have transformed autoimmune treatment, revolutionizing treatment for patients with...
GLP-1 RA prescription trends: January 2018 – December 2024
Overall prescribing rates (GLP-1 RA prescriptions per total prescriptions) in December 2024 were similar to September 2024 (+1.89%). Anti-diabetic medication (ADM) prescribing...
Real-world insights on heart failure recovery: A missed opportunity in guideline-directed therapy
Heart failure with reduced ejection fraction (HFrEF) remains a leading cause of morbidity and mortality. While guideline-directed medical therapy (GDMT) has been shown to improve...